NL189948C - Vast farmaceutisch preparaat dat een of een aantal beta-lactamantibiotica bevat. - Google Patents

Vast farmaceutisch preparaat dat een of een aantal beta-lactamantibiotica bevat.

Info

Publication number
NL189948C
NL189948C NLAANVRAGE8303125,A NL8303125A NL189948C NL 189948 C NL189948 C NL 189948C NL 8303125 A NL8303125 A NL 8303125A NL 189948 C NL189948 C NL 189948C
Authority
NL
Netherlands
Prior art keywords
lactamantibiotics
beta
pharmaceutical preparation
preparation containing
solid pharmaceutical
Prior art date
Application number
NLAANVRAGE8303125,A
Other languages
English (en)
Dutch (nl)
Other versions
NL189948B (nl
NL8303125A (nl
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8303125A publication Critical patent/NL8303125A/nl
Publication of NL189948B publication Critical patent/NL189948B/xx
Application granted granted Critical
Publication of NL189948C publication Critical patent/NL189948C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NLAANVRAGE8303125,A 1982-09-10 1983-09-09 Vast farmaceutisch preparaat dat een of een aantal beta-lactamantibiotica bevat. NL189948C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8225853 1982-09-10
GB8225853 1982-09-10

Publications (3)

Publication Number Publication Date
NL8303125A NL8303125A (nl) 1984-04-02
NL189948B NL189948B (nl) 1993-04-16
NL189948C true NL189948C (nl) 1993-09-16

Family

ID=10532830

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8303125,A NL189948C (nl) 1982-09-10 1983-09-09 Vast farmaceutisch preparaat dat een of een aantal beta-lactamantibiotica bevat.

Country Status (20)

Country Link
US (2) US4582830A (fr)
JP (1) JPS5973518A (fr)
KR (1) KR880001094B1 (fr)
AT (1) AT388671B (fr)
AU (1) AU566245B2 (fr)
BE (1) BE897721A (fr)
CA (1) CA1215647A (fr)
CH (1) CH655008A5 (fr)
DE (1) DE3332616C2 (fr)
DK (1) DK161304C (fr)
ES (1) ES525492A0 (fr)
FR (1) FR2532849B1 (fr)
GB (1) GB2126479B (fr)
IE (1) IE55720B1 (fr)
IT (1) IT1197708B (fr)
NL (1) NL189948C (fr)
NZ (1) NZ205539A (fr)
PT (1) PT77323B (fr)
SE (1) SE464615B (fr)
ZA (1) ZA836703B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
AT393452B (de) * 1985-08-05 1991-10-25 Bristol Myers Squibb Co Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
KR890701104A (ko) * 1987-05-27 1989-12-19 에지.지.제이.베르미렌, 에이.디.도우마 β-락탐 항생제의 급용해성 무수 조성물
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
EP0797974B1 (fr) * 1994-12-08 2000-08-30 Otsuka Pharmaceutical Factory, Inc. Procede pour supprimer l'adsorption de substances derivees du materiau recipient sur les medicaments
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
CA2239331C (fr) * 1998-05-29 1999-11-30 Bernard Charles Sherman Comprimes pharmaceutiques a base de cefuroxime axetil
ES2686898T3 (es) 2003-04-28 2018-10-22 Takeda Pharmaceutical Company Limited Composición para inyección
JP4700291B2 (ja) * 2003-04-28 2011-06-15 武田薬品工業株式会社 注射用組成物
EP1625859A1 (fr) * 2004-08-13 2006-02-15 Access Group ApS Procédé de préparation d'un emballage contenant substances stérilisées, et emballage contenant pénicilline stérilisée
CN102920710B (zh) * 2012-11-16 2014-05-28 罗诚 一种头孢地嗪化合物的药物组合物
CN103432137B (zh) * 2013-08-28 2015-01-28 芦红代 头孢西丁的药物组合物
CN113350511B (zh) * 2021-03-01 2024-01-02 郎俊娜 一种新型注射用无菌粉末灌装混合保护气

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB737242A (en) * 1952-10-16 1955-09-21 Novo Terapeutisk Labor As Process of increasing the physical stability of aqueous suspensions of penicillin compounds
GB760087A (en) * 1952-10-16 1956-10-31 Novo Terapeutisk Labor As Process of increasing the physical stability of aqueous suspensions of penicillin compounds
GB1132583A (en) * 1964-12-16 1968-11-06 Glaxo Lab Ltd Pharmaceutical compositions containing cephalosporins
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions
AT307616B (de) * 1969-05-02 1973-05-25 Biochemie Gmbh Verfahren zur Herstellung einer Brausezubereitung
GB1380741A (en) * 1971-02-05 1975-01-15 Squibb & Sons Inc Antibiotic compositions and their preparation
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
LU65921A1 (fr) * 1972-08-18 1974-02-21
US4160829A (en) * 1972-12-22 1979-07-10 Gist-Brocades N.V. Antibacterial 1,2,4-oxadiazolylacetamido cephalosporins
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
DE2461969A1 (de) * 1974-12-31 1976-07-08 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
CA1051780A (fr) * 1975-04-09 1979-04-03 Bahram Farhadieh Compose stable de chelocardin
GB1575905A (en) * 1976-04-28 1980-10-01 Glaxo Lab Ltd Salt of cefuroxime
GB1504767A (en) * 1976-08-23 1978-03-22 Beecham Group Ltd Antibiotic compositions
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
IT1109207B (it) * 1977-10-10 1985-12-16 Glaxo Group Ltd Composti b-lattamici composizioni antibiotiche che li contengono e procedimento per prepararli
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic

Also Published As

Publication number Publication date
GB8324133D0 (en) 1983-10-12
FR2532849A1 (fr) 1984-03-16
PT77323A (en) 1983-10-01
AU1897583A (en) 1984-03-15
SE464615B (sv) 1991-05-27
IT8348950A0 (it) 1983-09-09
DK409183A (da) 1984-03-11
ES8502863A1 (es) 1985-02-01
AT388671B (de) 1989-08-10
GB2126479A (en) 1984-03-28
NL189948B (nl) 1993-04-16
ZA836703B (en) 1984-10-31
PT77323B (en) 1986-02-06
DK161304C (da) 1991-12-02
KR880001094B1 (ko) 1988-06-29
DK409183D0 (da) 1983-09-09
CA1215647A (fr) 1986-12-23
CH655008A5 (de) 1986-03-27
NL8303125A (nl) 1984-04-02
AU566245B2 (en) 1987-10-15
KR840006126A (ko) 1984-11-22
DE3332616A1 (de) 1984-03-15
US4803196A (en) 1989-02-07
NZ205539A (en) 1986-03-14
US4582830A (en) 1986-04-15
IE55720B1 (en) 1991-01-02
DK161304B (da) 1991-06-24
IE832118L (en) 1984-03-10
ATA322783A (de) 1989-01-15
BE897721A (fr) 1984-03-09
JPH0480883B2 (fr) 1992-12-21
GB2126479B (en) 1986-04-03
DE3332616C2 (de) 1995-06-01
SE8304857L (sv) 1984-03-11
IT1197708B (it) 1988-12-06
FR2532849B1 (fr) 1986-08-22
ES525492A0 (es) 1985-02-01
SE8304857D0 (sv) 1983-09-09
JPS5973518A (ja) 1984-04-25

Similar Documents

Publication Publication Date Title
DK68392A (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
NL930032I2 (nl) 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydronafyridine-3-carbozuren, werkwijzen ter bereiding ervan en deze bevattende geneesmiddelen.
FI822005L (fi) Antifungisida aemnen, foerfarande foer deras framstaellning, och dessa innehaollande farmaceutiska sammansaettningar
NL193457B (nl) Benzoheterocyclische verbindingen en farmaceutisch preparaat dat een dergelijke verbinding bevat.
DK481585D0 (da) Farmaceutisk praeparat indeholdende anthracyclinglycosider
PT73686A (pt) Pharmaceutical formulation
DK345682A (da) Pharmaceutiske expienser
DK37981A (da) Kapsler indeholdende cementholdige blandinger
BE894376A (fr) Preparation pharmaceutique
NL189561B (nl) Gesubstitueerde cyclo-alkylideenmethylfenylazijnzuurverbindingen, alsmede een farmaceutisch preparaat, dat deze verbindingen bevat.
NL189948C (nl) Vast farmaceutisch preparaat dat een of een aantal beta-lactamantibiotica bevat.
FI823544L (fi) Triazinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar
FI810056L (fi) Farmaceutiska foereningar
DE3279806D1 (de) Corpuscules containing medicaments
FI821167A0 (fi) Lokalt anvaendbara farmaceutiska kompositioner, som innehaoller antiinflammatoriska steroider
DK521487A (da) Farmaceutisk praeparat indeholdende et resorptionsforbedrende middel
NL184146C (nl) Farmaceutisch preparaat dat een vinca-alkaloide bevat.
ZA818221B (en) Pharmaceutical compounds
FI831687A0 (fi) Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar
DK314283D0 (da) Farmaceutiske praeparater
NO811003L (no) Farmasoeytiske preparater.
AR226334A1 (es) Procedimiento para fabricar preparados farmaceuticos
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
NL193821B (nl) Farmaceutisch preparaat.
BE891013A (fr) Compositions pharmaceutique

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20030909